Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse

Journal Article · Tue Sep 01 04:00:00 EDT 2015 · Toxicology and Applied Pharmacology

DOI:https://doi.org/10.1016/J.TAAP.2015.05.019· OSTI ID:22465815

Siddens, Lisbeth K. ^[1]; Bunde, Kristi L. ^[2]; Harper, Tod A. ^[1]; McQuistan, Tammie J. ^[3]; Löhr, Christiane V. ^[4]; Bramer, Lisa M. ^[5]; Waters, Katrina M. ^[3]; Tilton, Susan C. ^[1]; Krueger, Sharon K. ^[1]; others, and

---

1. Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331 (United States)
2. College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331 (United States)
3. Superfund Research Center, Oregon State University, Corvallis, OR 97331 (United States)
4. Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331 (United States)
5. Applied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, WA 99352 (United States)

FVB/N mice wild-type, heterozygous or null for Cyp 1b1 were used in a two-stage skin tumor study comparing PAH, benzo[a]pyrene (BaP), dibenzo[def,p]chrysene (DBC), and coal tar extract (CTE, SRM 1597a). Following 20 weeks of promotion with TPA the Cyp 1b1 null mice, initiated with DBC, exhibited reductions in incidence, multiplicity, and progression. None of these effects were observed with BaP or CTE. The mechanism of Cyp 1b1-dependent alteration of DBC skin carcinogenesis was further investigated by determining expression of select genes in skin from DBC-treated mice 2, 4 and 8 h post-initiation. A significant reduction in levels of Cyp 1a1, Nqo1 at 8 h and Akr 1c14 mRNA was observed in Cyp 1b1 null (but not wt or het) mice, whereas no impact was observed in Gst a1, Nqo 1 at 2 and 4 h or Akr 1c19 at any time point. Cyp 1b1 mRNA was not elevated by DBC. The major covalent DNA adducts, dibenzo[def,p]chrysene-(±)-11,12-dihydrodiol-cis and trans-13,14-epoxide-deoxyadenosine (DBCDE-dA) were quantified by UHPLC-MS/MS 8 h post-initiation. Loss of Cyp1 b1 expression reduced DBCDE-dA adducts in the skin but not to a statistically significant degree. The ratio of cis- to trans-DBCDE-dA adducts was higher in the skin than other target tissues such as the spleen, lung and liver (oral dosing). These results document that Cyp 1b1 plays a significant role in bioactivation and carcinogenesis of DBC in a two-stage mouse skin tumor model and that loss of Cyp 1b1 has little impact on tumor response with BaP or CTE as initiators. - Highlights: • Cyp1b1 null mice exhibit lower skin cancer sensitivity to DBC but not BaP or CTE. • Cyp1b1 expression impacts expression of other PAH metabolizing enzymes. • cis/trans-DBCDE-dA ratio significantly higher in the skin than the spleen, lung or liver • Potency of DBC and CTE in mouse skin is higher than predicted by RPFs.

• OSTI ID: 22465815
• Journal Information: Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 2 Vol. 287; ISSN TXAPA9; ISSN 0041-008X
• Country of Publication: United States
• Language: English

Related Subjects

60 APPLIED LIFE SCIENCES
ANIMAL TISSUES
CARCINOGENESIS
CHRYSENE
COAL TAR
DNA ADDUCTS
ENZYMES
EPITHELIOMAS
EPOXIDES
GENES
GLUTATHIONE
LIVER
LUNGS
MESSENGER-RNA
MICE
POLYCYCLIC AROMATIC HYDROCARBONS
PYRENE
SKIN
SPLEEN
TOXICITY